Field Trip Health Ltd. Provides Operational and Investor Update, Announces Expanded Hours at its Field Trip Health Center in Toronto plus Rollout of Portal, Field Trip’s Proprietary Digital Mental Health Platform Dec 4 • 4 min read Field Trip Health Ltd. announced that it is expanding the hours of operation at its Toronto Field Trip Health location to provide its psychedelic therapies on evenings and Saturdays.
Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific Dec 4 • 3 min read Entheon Biomedical Corp. announced a strategic investment in Wonder Scientific Inc.
Epidemiologist Dr. Joel Moody Joins Revive Therapeutics as Medical and Clinical Advisor Dec 3 • 3 min read Revive Therapeutics Ltd. announced the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the company.
CaaMTech Collaborates With the Leibniz Institute for Natural Product Research to Investigate Psychedelic Mushrooms Dec 2 • 2 min read CaaMTech, Inc. announced that they have entered into a collaborative research agreement to research psychedelic mushroom compositions.
Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial Dec 2 • 5 min read Numinus Wellness Inc. and the Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation announced a collaboration agreement that will seek approval to deliver MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD).